🇺🇸 FDA

Drug profile · INN

capsaicin

QUTENZA

approved N01BX04
US status
approved
Patents linked
5
News articles
0

Quick answer

capsaicin (QUTENZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN capsaicin
Brand QUTENZA
Route TOPICAL
Formulation PATCH
ATC code N01BX04

Related patents

Search patents →

  1. US 7097991

    Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof

    Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 6790629

    Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof

    Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6335180

    Nucleic acid sequences encoding capsaicin receptor and uses thereof

    Expires Mon Dec 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6248788

    Therapeutic method with capsaicin and capasicin analogs

    Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6239180

    Transdermal therapeutic device and method with capsaicin and capsaicin analogs

    Expires Mon May 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is capsaicin?

capsaicin (QUTENZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for capsaicin?

QUTENZA is a marketed brand name for capsaicin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of capsaicin?

capsaicin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.